CRVS - Corvus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2223
Avg. Estimate-0.4-0.41-1.66-1.89
Low Estimate-0.41-0.42-1.72-2.07
High Estimate-0.39-0.41-1.6-1.78
Year Ago EPS-0.63-0.4-1.71-1.66
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts1122
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.74-0.59-0.48-0.46
EPS Actual-0.63-0.4-0.36-0.36
Difference0.110.190.120.1
Surprise %14.90%32.20%25.00%21.70%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.4-0.41-1.66-1.89
7 Days Ago-0.4-0.41-1.66-1.89
30 Days Ago-0.4-0.42-1.66-1.9
60 Days Ago-0.48-0.53-1.81-1.83
90 Days Ago-0.49-0.52-1.84-1.8
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days11N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCRVSIndustrySectorS&P 500
Current Qtr.36.50%N/AN/A-0.02
Next Qtr.-2.50%N/AN/A0.04
Current Year2.90%N/AN/A0.05
Next Year-13.90%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A